Skip to main content
letter
. 2006 Apr;50(4):1608–1609. doi: 10.1128/AAC.50.4.1608-1609.2006

TABLE 1.

Extended antibiogram, PCR, and sequence analysis results for isolates confirmed as ESBL producers by phenotypic methods

Isolate no. Yr Serotype Source Extended antibiograma MICb (μg/ml)
PCR (TEM, SHV, CTX-M) Sequence analysis Foreign travel
TZ CT PM
227 2005 Typhimurium Human ACSSuTMnCpd 0.5 4 16 Negative N/A Andorrac
142 2005 Concord Human ACSSuTTmGm     MnCzCtxCpd >256 >32 >16 TEM and CTX-M positive CTX-M-15 and TEM-1 Ethiopia
695 2004 Typhimurium Human ACtxCpd 4 >32 >16 CTX-M positive CTX-M-14 None
172 2003 Typhimurium Human ACSSuTTmMn     SpCzCtxCpd >256 >32 >16 CTX-M positive CTX-M-15 Africa
174 2003 Unnamed (O4,12; H?) Avian ASuTmSpCzCtx >256 >32 4 TEM positive TEM-52 NAd
279 2002 Worthington Human ASNaKGmSpCz     CtxCpd >256 >32 1.5 TEM and SHV positive SHV-12 and TEM-1 India
1016 2001 Java Beef ASTmNaSpCpd 4 6 2 TEM positive TEM-20 NA
a

A, ampicillin; C, chloramphenicol; S, streptomycin; Su, compound sulfonamides; T, tetracycline; Tm, trimethoprim; K, kanamycin; Gm, gentamicin; Mn, minocycline; Na, nalidixic acid; Sp, spectinomycin; Cz, ceftazidime; Ctx, cefotaxime; Cpd, cefpodoxime.

b

TZ, ceftazidime; CT, cefotaxime; PM, cefepime.

c

The Principality of Andorra is located in southwestern Europe, bordered by France and Spain.

d

NA, not applicable.